--- title: "Dr. Josep María Fábregas Pedrell, speaker at the 19th National Congress of Private Psychiatry in Murcia" description: "A leading conference for Spanish private psychiatry Spanish psychiatry is undergoing a period of profound transformation. New therapeutic approaches, technologies applied to mental health, and an..." url: https://clinicascita.com/en/dr-fabregas-xix-congress-private-psychiatry-2026/ date: 2026-04-29 modified: 2026-04-29 author: "Clínicas CITA" image: https://clinicascita.com/wp-content/uploads/drogas-o-medicamentos.jpg categories: ["blog"] tags: ["reconocimientos"] type: post lang: en --- # Dr. Josep María Fábregas Pedrell, speaker at the 19th National Congress of Private Psychiatry in Murcia ## A leading conference for Spanish private psychiatry Spanish psychiatry is undergoing a period of profound transformation. New therapeutic approaches, technologies applied to mental health, and an increasingly open scientific debate on substances that were taboo until recently are redrawing the map of psychiatric care in our country. In this context, **Dr. Josep María Fábregas Pedrell**, director of **Clínicas CITA**, attended from **March 12 to 14, 2026** in Murcia as an **invited speaker** at the **XIX National Congress of Private Psychiatry**, one of the most important scientific forums in the sector in Spain. The National Congress of Private Psychiatry is the biennial meeting that brings together the main mental health specialists from the private sector across the country. Over three intense days, psychiatrists, clinical psychologists, researchers, and healthcare managers share knowledge, debate the latest advances in diagnosis and treatment, and outline the evolution of a discipline that gains more social visibility each year. The 2026 edition, held in Murcia, focused on two major thematic axes: innovation in private psychiatric hospitalization models and the emerging role of psychedelics as a therapeutic tool. Dr. Fábregas played a prominent role in both. !(https://clinicascita.com/wp-content/uploads/innovacion-y-colaboracion-en-hospitalizacion.jpg) ## Innovation and collaboration in hospital treatments Dr. Fábregas’s first intervention took place in the session titled **“Hospital treatments in the private sector: innovation and collaboration”**. This panel brought together experts from different centers to analyze how psychiatric hospitalization in Spain is evolving outside the public system: which models work best, what challenges comprehensive care for hospitalized patients presents, and how collaboration between private centers can improve clinical outcomes. For Clínicas CITA, hospitalization is one of the fundamental pillars of its care model. The center has specialized units for the treatment of addictions and dual pathology — the combination of an addiction with another mental disorder such as depression, anxiety, or schizophrenia — where hospital intervention plays a crucial role in the most complex cases. The experience accumulated over decades in this type of treatment makes Dr. Fábregas a particularly authoritative voice to speak about innovation and collaborative work in this field. ## The debate on psychedelics reaches Spanish private psychiatry Undoubtedly, one of the most anticipated sessions of the congress was the **Round Table “Psychedelics: from stigma to prescription”**. Few conversations are generating as much interest in the international scientific community as the one surrounding the therapeutic use of substances such as psilocybin, MDMA, or ketamine. For decades, these substances were exclusively associated with recreational use and abuse, which greatly hindered their research and eventual clinical application. However, in recent years, a wave of studies published in the world’s most prestigious scientific journals has shown that some of these molecules have real therapeutic potential in treating disorders such as resistant depression, PTSD (post-traumatic stress disorder), or addictions. In this scenario, Dr. Fábregas presented his paper titled **“Drug or medication: the view from the clinic”**, a deep and honest reflection on how this reality is seen from the front line of clinical practice. Because if there is something that distinguishes Dr. Fábregas’s perspective, it is precisely that: years of direct experience working with patients struggling with addictions, which allows him to analyze the phenomenon of psychedelics without idealism, but also without prejudice. The question raised by the title of his paper — drug or medication? — is not rhetorical. It is, in fact, the central knot of a debate with enormous scientific, ethical, regulatory, and social implications. Under what conditions can a substance considered a drug become a legitimate medication? What does the available clinical evidence say? What precautions should be taken? How is communication with the patient and society managed regarding these emerging therapies? These are the questions that leading specialists are trying to answer, and Clínicas CITA, through its director, is an active part of that conversation. !(https://clinicascita.com/wp-content/uploads/drogas-o-medicamentos.jpg)   ## Clínicas CITA, committed to knowledge and innovation The participation of (https://clinicascita.com/autor/josep-maria-fabregas-pedrell/) in the XIX National Congress of Private Psychiatry is not an isolated event. It reflects a way of understanding medicine: one that is not content with the established, that constantly seeks new answers for the most difficult-to-treat patients, and that understands scientific knowledge as a living tool, in permanent evolution. Clínicas CITA has been a benchmark in the treatment of addictions in Spain for decades. Its model combines specialized medical care, individual and group psychotherapy, and family support in a comprehensive approach that has helped thousands of patients regain their quality of life. That its director is invited to share his experience and reflections in the most relevant scientific forums in the country is both a recognition of his career and a demonstration of the center’s high level of care and research. At Clínicas CITA, we are proud to have professionals who not only treat their patients with rigor and dedication but also contribute to the continued advancement of Spanish psychiatry.